CapsoVision, a medical device developer, submitted an application Nov. 6 to the FDA requesting breakthrough device designation for its CapsoCam UGI capsule, aimed at detecting early-stage pancreatic ...
Pancreatic ductal adenocarcinoma — the most common form of pancreatic cancer — is among the deadliest cancers worldwide, with a five-year survival rate of only 8%, largely because it is diagnosed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback